Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal ArticleDOI
Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development.
TL;DR: Findings indicate that this method of protein deimmunization based on the point mutation of highly hydrophilic R, K, D, E, and Q amino acids on the molecular surface of truncated diphtheria-toxin may be effective for deimmunitionizing of other proteins and that discovery of a deim immunized form of DT may lead to the development of more effective targeted toxin.
Journal ArticleDOI
Patient-specific Boolean models of signalling networks guide personalised treatments
Arnau Montagud,Jonas Béal,Luis Tobalina,Pauline Traynard,Vigneshwari Subramanian,Bence Szalai,Róbert Alföldi,László G. Puskás,Alfonso Valencia,Emmanuel Barillot,Julio Saez-Rodriguez,Laurence Calzone +11 more
TL;DR: In this paper , the authors developed a mathematical model of prostate cancer which considers the major signalling pathways known to be deregulated and personalised this Boolean model to molecular data to reflect the heterogeneity and specific response to perturbations of cancer patients.
Journal ArticleDOI
Photoactivated inhibition of cathepsin K in a 3D tumor model.
Mackenzie K. Herroon,Rajgopal Sharma,Erandi Rajagurubandara,Claudia Turro,Jeremy J. Kodanko,Izabela Podgorski +5 more
TL;DR: The results suggest that light activation provides a suitable, attractive approach for spatial and temporal control of proteolytic activity, which remains a critical, unmet need in treatment of human diseases, especially cancer.
Patent
GTPase inhibitors and methods of use
TL;DR: In this article, the Rho family GTPases (Rac, Rac1, Rac2 and/or Rac3) have been used in a variety of applications, e.g., screening for compounds which recognize Rac GTPase, and methods of treating pathological conditions associated or related to a Rho-GTPase including Rac.
Journal ArticleDOI
Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells.
TL;DR: Results showed how tethering IL2 to its receptor IL2Rβ eliminates the need forIL2Rα and IL2 Rβ, offering a new tool to selectively activate and empower immune therapy.